» Articles » PMID: 32445376

Expression of Daratumumab and Elotuzumab Migration by Capillary Electrophoresis Relative to Transferrin Improves Precision of Their Identification

Overview
Journal J Appl Lab Med
Specialty Biochemistry
Date 2020 May 24
PMID 32445376
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Use of a Daratumumab-Specific Immunofixation Assay to Assess Possible Immunotherapy Interference at a Major Cancer Center: Our Experience and Recommendations.

Kirchhoff D, Murata K, Thoren K J Appl Lab Med. 2021; 6(6):1476-1483.

PMID: 34293131 PMC: 9487159. DOI: 10.1093/jalm/jfab055.